baber/WOPTO huggingface dataset:
Patent JP-3613604-B2 (JP)
IPC: A61J1/00
Filed: 1998-11-19
Granted: 2005-01-26
Abstract: The hypodermic syringe, and especially a prefilled syringe, has an elastic seal (2) within the safety cap (1). The elastic seal projects, as a plug, into the central opening (10) of the closure section (3) to bear against the surface of the syringe seal (5). The safety cap is covered by a shrink film.
Patent JP-3287593-B2 (JP)
IPC: B01J21/08
Filed: 1991-11-27
Granted: 2002-06-04
Abstract: The invention relates to a process for the preparation of beta-isophorone from alpha-isophorone, alpha-isophorone being converted to beta-isophorone in the gas phase in the presence of a heterogeneous catalyst. The heterogeneous catalyst used is in particular an oxide or mixed oxide of the elements Mg, Al, Si and Ni.
Patent JP-2739687-B2 (JP)
IPC: C08F4/642
Filed: 1996-12-18
Granted: 1998-04-15
Abstract: Treatment process making it possible to maintain the morphology of a catalyst component for the gas-phase polymerisation or copolymerisation of ethylene or of ethylene and of at least one alpha olefin containing from 3 to 12 carbon atoms, the said component containing at least titanium, magnesium, chlorine and optionally an electron-donor, the process consisting, after impregnation of a porous metal oxide support with titanium, magnesium and chlorine compounds and optionally with the electron-donor, in involving this catalyst component in the presence of an alkylaluminium-based cocatalyst in a prepolymerisation, at least partially in suspension, of ethylene or of ethylene and of an alpha-olefin characterised in that the prepolymerisation is conducted, in the presence of a cocatalyst consisting of an alkylaluminium complexed with an electron-donor to a degree of prepolymerisation appropriate to the gas-phase polymerisation process in which the resulting active prepolymer will subsequently be used.
Patent JP-4276295-B2 (JP)
IPC: C12N5/00
Filed: 1996-06-03
Granted: 2009-06-10
Abstract: Chimeric proteins useful in transporting a selected substance present in extracellular fluids, such as blood or lymph, into cells; quantitative assays for the selected substance using chimeric proteins; DNA encoding the chimeric proteins; plasmids which contain DNA encoding the chimeric proteins; mammalian cells, modified to contain DNA encoding the chimeric proteins, which express and, optionally, secrete the chimeric proteins; a method of producing the chimeric proteins; a method of isolating the chimeric proteins; a method of using the chimeric proteins to assay the selected substance; and a method of reducing extracellular levels of the selected substance through administration of the chimeric protein, which results in transport of the selected substance into cells.
Patent JP-3130935-B2 (JP)
IPC: A61P1/16
Filed: 1992-06-18
Granted: 2001-01-31
Abstract: The invention concerns novel pharmaceutical compositions containing as an active ingredient a 2-benzoyl-1,3-cyclohexanedione which is an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD). The compositions are valuable in the treating those disorders and diseases in which it is desirable to intervene in the metabolic sequences catalysed by HPPD, such as in treating tyrosinemia type I.
Patent JP-3789477-B2 (JP)
IPC: A44C5/10
Filed: 1996-07-09
Granted: 2006-06-21
Abstract: PCT No. PCT/BE96/00074 Sec. 371 Date Dec. 10, 1997 Sec. 102(e) Date Dec. 10, 1997 PCT Filed Jul. 9, 1996 PCT Pub. No. WO97/03294 PCT Pub. Date Jan. 30, 1997Method for fixing two elements together, in particular links (1) of a metal wristwatch strap, according to which a metal pin (2) made of a moulding memory alloy with large hysteresis-programmed such that it turns from the martensitic structure to the austenitic structure in a first temperature range which is situated above the service temperature of the elements and whereby its thickness increases, and such that it turns back from the austenitic structure to the martensitic structure in a second temperature range which is situated under the above-mentioned service temperature-is clamped in the martensitic structure in at least one either or not blind hole (3) in at least one of the elements to be linked; the pin (2) is subsequently heated to a temperature higher than the first temperature range, such that the thickness of the pin (2) is increased, whereby the clamping force of the pin (2) in the hole (3) becomes very large; and the pin (2) is finally cooled down to service temperature, characterized in that a pin (2) with a martensitic structure is put in at least one hole (3) having a thickness which is slightly larger than the width of the hole (3).
Patent JP-2547055-B2 (JP)
IPC: B09B1/00
Filed: 1987-09-16
Granted: 1996-10-23
Abstract: PCT No. PCT/EP87/00528 Sec. 371 Date May 18, 1988 Sec. 102(e) Date May 18, 1988 PCT Filed Sep. 16, 1987 PCT Pub. No. WO88/01913 PCT Pub. Date Mar. 24, 1988.This container system is designed in such a way that wastes which cannot be differentiated according to their effects can be stored for an indefinite period in the system which is self-contained and hence cut off from the environment, and these wastes can also be recovered at any time without polluting the environment. For this purpose this container concept is designed as a double-walled system, consisting of an inner container (2) as a casing for the waste and an outer container (1) as a protective container, with an air space as an inspection and working chamber (4) between the two. The inner container (2) is designed in such a way that it can be visually, mechanically, chemically and/or biologically checked, repaired and renewed completely and on all sides at any time while full.
Patent JP-2701908-B2 (JP)
IPC: G01N33/574
Filed: 1988-11-10
Granted: 1998-01-21
Abstract: A method of detecting and/or measuring the terminal glycosylation of a protein by estimating, preferably using labelled lectins, the relative proportions of different terminal sugars which may be present in the protein, is useful in providing a prognosis for various conditions, particularly breast cancer.
Patent JP-3705813-B2 (JP)
IPC: A61F13/494
Filed: 1995-09-08
Granted: 2005-10-12
Abstract: Absorbent articles having side panels that provide inflected barrier cuffs which promotes better containment and fit. The absorbent articles comprise a liquid pervious topsheet, a liquid impervious backsheet, an absorbent core positioned between the topsheet and the backsheet; a side panel extending laterally from each longitudinal edge of the absorbent article and having a proximal edge, a distal edge and a fold intermediate the distal edge and the proximal edge; spacing means for spacing the distal edge away from the liquid-receiving surface (topsheet) of the absorbent article; and a closing means for securing the distal edges inboard of the proximal edges in the front waist region. The fold of the side panel is secured inboard of the proximal edges in the front waist region and is disposed outboard of the proximal edge in the rear waist region when fitted to the wearer. Thus, the side panels are inflected such that the portion of the side panels in the rear waist region provide a gasketing action about the buttocks of the wearer to contain exudates and a snug fit, while the stand-up portions of the side panels in the crotch region and the closed portion of the side panels in the front waist region provide channels to contain, restrain and hold body exudates.
Patent JP-3218318-B2 (JP)
IPC: C12Q1/6888
Filed: 1989-10-11
Granted: 2001-10-15
Abstract: A process for analyzing length polymorphism in DNA regions wherein the following steps are carried out:(a) annealing at least one primer pair to the DNA to be analyzed, wherein one of the molecules of the primer pair is substantially complementary to one of the complementary strands of the 5' or 3' flank of a simple or cryptically simple DNA sequence, and wherein the annealing occurs in such an orientation that the synthesis products obtained by a primer-controlled polymerisation reaction with one of said primers can serve as template for annealing the other primer after denaturation;(b) primer-controlled polymerase chain reaction; and(c) separating and analyzing the polymerase chain reaction products.
Patent JP-3936735-B2 (JP)
IPC: B32B27/08
Filed: 1995-09-22
Granted: 2007-06-27
Abstract: PCT No. PCT/NL95/00318 Sec. 371 Date Jun. 2, 1997 Sec. 102(e) Date Jun. 2, 1997 PCT Filed Sep. 22, 1995 PCT Pub. No. WO96/09928 PCT Pub. Date Apr. 4, 1996The invention provides a light-transmitting cover foil intended to be arranged adheringly to a surface, for instance the surface of a carrier plate, optionally bearing information such as letters, numbers, images or the like, which foil consists of a laminate comprising: a first layer plastically deformable only at a relatively high first temperature, for instance in the range of 120 DEG  C.-200 DEG  C. and comprising for instance polycarbonate, PMMA, PVC, ABS, PP, PE, which first layer is provided before, during or after joining together to the other layers with a structure, for instance a texture and/or pattern pressed out of its main surface by exerting pressure and increasing temperature to at least the said first temperature, for instance by applying a heated profile roller; a second layer adhered thereto consisting of a dimensionally stable carrier layer comprising for instance polycarbonate, PMMA, PVC, polyester/PET, ABS; and a third layer adhered thereto which is meltable and thus thermally-activated at a relatively low second temperature, for instance in the range of 50 DEG  C.-90 DEG  C. and which consists of a hot-melt layer or glue layer, comprising for instance EVA, EEA, EBA, EMA, GBA or other low-melting plastics including polyolefins and copolymer esters, polyacetate esters, softened PVCs; which said layers are mutually connected by adhesive agents, for instance by making use of coextrusion.
Patent JP-2845622-B2 (JP)
IPC: A61K38/20
Filed: 1990-09-19
Granted: 1999-01-13
Abstract: A method of inhibiting the development of malignant tumors and the formation of metastases of malignant tumor cells in a subject carrying the comprises administering to the subject IL-2 and an agent selected from the group consisting of histamine, a histamine structural analogs having H2-receptor activities, an endogenous histamine releasing preparation, and a non-histamine derivative H2-receptor agonist; the agent and the IL-2 being administered in amounts and for a time effective to attain the desired effect. A method of increasing the anti-tumor cell effect of IL-2 in a subject comprises co-administering to the subject IL-2 and an agent such as histamine, histamine structural analogs having H2-receptor activities, endogenous histamine releasing preparations or H2-receptor agonists, the agent and the IL-2 being administered in anti-tumor effective amounts and for a period of time effective to attain the desired effect.
Patent JP-2793719-B2 (JP)
IPC: A61K38/08
Filed: 1994-11-09
Granted: 1998-09-03
Abstract: The present invention provides novel cytokine restraining agents, which limit or control the biological activity of cytokines. The invention also provides pharmaceutical compositions comprising a cytokine restraining peptide and methods of administering the pharmaceutical composition to a subject. The invention further provides methods for using the novel peptides to restrain cytokine activity in a subject.
Patent JP-3563076-B2 (JP)
IPC: C07D487/04
Filed: 1996-12-02
Granted: 2004-09-08
Abstract: Disclosed is a pyrroloazepine derivative or a salt thereof. The pyrroloazepine derivative is represented by the following formula (I): <CHEM>  wherein     the ring P represented by <CHEM>  means a pyrrole ring represented by the following structure: <CHEM> in which R1 represents alkyl, cycloalkyl or the like, and R2 represents H or alkyl; the dashed line indicates the presence or absence of a bond; and, when the bond is present, Z2 is not present/and Z1 represents H but, when the bond is absent, Z1 and Z2 are both H; Z1 represents H and Z2 represents a group OR3 in which R3 represents H, alkyl, aralkyl or the like; Z1 and Z2 both represent groups SR4 in which R4 represents alkyl, aralkyl or the like; or Z1 and Z2 are combined together to represent O, a group NOR5 in which R5 represents H, alkyl or the like, or a C2-C3 alkylenedithio; A represents alkylene, alkenylene or alkynylene; and Y represents a group <CHEM> in which W represents CH, C= or N, m stands for 0 or 1, n stands for 1, 2 or 3, G represents O, S, C=O, sulfinyl, sulfonyl, alkylene, alkenylene, acetal or the like; E1 and E2 represent H or lower alkyl group; and D represents an aromatic hydrocarbon or am aromatic heterocyclic ring. The compound (I) has strong serotonin-2 receptor antagonistic action and low toxicity and less side effects, and is useful as a therapeutic for circulatory diseases such as ischemic heart diseases, cerebrovascular disturbances and peripheral circulatory disturbances.
Patent JP-3219774-B2 (JP)
IPC: B65D43/10
Filed: 1996-12-12
Granted: 2001-10-15
Abstract: Disclosed is a closure for a container, such as a blow molded jug having a neck surrounding an opening therein, the closure having a first annular portion and a second annular portion. The first annular portion in the closure has a wiper seal and a lip seal. The second annular portion exerts an upward pressure on the lip seal which causes improved sealing and leak-tight properties during shipping, handling, etc. The upward pressure also enhances the effectiveness of the wiper seal. The second annular portion may include an annular tear skirt having a pull tab for the removal thereof to facilitate removal of the closure from the container. The closure may also include a plug seal, and a lower annular portion extending from the second annular portion.
Patent JP-4006026-B2 (JP)
IPC: D01D5/24
Filed: 1997-11-24
Granted: 2007-11-14
Abstract: A nonwoven filter media or mat (10) formed from a plurality of elongated generally hollow fibers (20) each having an internal cavity (22) which has an opening (24), smaller than the cavity width, to the fiber (20) surface and each retaining within the internal cavity (22) a large number of relatively small solid particles (18). The small solid particles (18), which can be an adsorbent such as activated carbon, are permanently entrapped within the longitudinal cavities (22) of the fibers (20) without the use of an adhesive.
Patent JP-3424174-B2 (JP)
IPC: C07D409/14
Filed: 1994-04-22
Granted: 2003-07-07
Abstract: The present invention relates to substituted pyrrolidinyl-3-yl-alkyl-piperidines, their stereoisomers, and pharmaceutically acceptable salts thereof and processes for preparation of the same. The compounds of the present invention are useful in their pharmacological activities such as tachykinin antagonism, especially substance P and neurokinin A antagonism, and the like. Compounds having the property of tachykinin antagonism are indicated for conditions associated with neurogenic inflammation and other diseases described herein.
Patent MD-2220-B2 (MD)
Title: Heterojunction sensor of toxic gases
Inventor: MIRON VALERIU
IPC: G01N27/12
Filed: 2000-09-28
Abstract: The invention relates to the semiconductor engineering, in particular to the semiconductor sensors of toxic gases and may be used for detection of toxic gases with small concentrations. The sensor includes an isolating substrate, onto which is deposited a sensitive layer, and electrodes. The sensitive layer contains a layer of chalcogenic semiconductor glass, onto which there is deposited a layer of tellurium or alloys thereof. Claims: 1Fig.: 4
Patent AU-2002233103-B2 (AU)
Title: Implants, device and method for joining tissue parts
Inventor: MAYER JORG
IPC: A61B17/80
Filed: 2002-03-04
Granted: 2006-11-02
Abstract: A method for locating a material having thermoplastic properties in pores of bone tissue includes providing a pin having the material having thermoplastic properties and a core, wherein the material having thermoplastic properties is arranged on the circumferential surface of the core constituting an outer region of the pin. An opening is provided in the bone tissue, and the pin is positioned at least partly in the opening. The outer region of the pin is then impinged with mechanical vibration energy for a time sufficient for liquefying at least part of the material having thermoplastic properties, and, in a liquefied state, pressing it into the pores of the bone tissue surrounding the opening. The vibration energy is stopped for a time sufficient for re-solidification of the liquefied material, and then the core is removed.
Patent AU-2002253282-B2 (AU)
Title: Dynamic balance board
Inventor: RAFFERTY DANIEL
IPC: A63B22/18
Filed: 2002-04-03
Granted: 2007-03-29
Abstract: A dynamic balance board is described that incorporates a means for providing objective measurements on a user's dynamic balance. The balance board comprises a top board, a rocker base and a plurality of force sensitive transducers strategically positioned on the rocker base. When a user stands on the top board the rocker base permits the oscillation of the top board about an equilibrium position. The force sensitive switches then provide output information regarding the angle of the top board and the rotational movement of the balance board relative to the equilibrium position. By monitoring the output information the dynamic balance board provides an objective measurement of the user's ability to balance on the top board.
Patent AU-2002310704-B2 (AU)
Title: Expansion valve fitted with a connector that is designed for the connection of a user socket
Inventor: GOUNOT ETIENNE
IPC: G05D16/10
Filed: 2002-04-19
Granted: 2005-11-24
Abstract: A fluid expansion valve with a main body and a method of its use. The main body has an internal fluid passage and an outlet connector. The outlet connector is suitable for delivering the expanded fluid and for connecting with a socket. The internal profile of the socket is suited for connection with the external profile of the outlet connect. The outlet connect has three connention sections of varying external diameters. The valve may be used to introduce a pressurized gas to a liquid or a beverage.
Patent AU-2003232922-B2 (AU)
Title: A crane assembly
Inventor: MCKAY DOUGLAS MCGREGOR
IPC: B66C1/00
Filed: 2003-05-30
Granted: 2007-02-01
Abstract: A lifting assembly comprising parallel guides (18, 20), a carriage (26, 28) associated with each parallel guide (18, 20) and movable along the length of the parallel guides, a displacement arm (40) pivotally connected to each carriage (26, 28) and pivotally supporting a bridge (14), preferably a trolley (13) located on the bridge (14) including attachment means (12) for supporting a lifting device.
Patent AU-2004200548-B2 (AU)
Title: Capsule magazine unit having a holding device for the capsule magazine unit, in particular of an espresso machine
Inventor: FISCHER DANIEL
IPC: A47J31/44
Filed: 2004-02-10
Granted: 2009-09-24
Abstract: Capsule magazine unit having a holding device for capsule magazine unit, into which the capsule magazine unit (1) can be releasably inserted, in particular of an espresso machine, the capsule magazine unit (1) comprising at least one essentially vertical capsule magazine tube (2 to 7) which is suitable for holding coffee capsules (12 to 14) stacked one above another and has a lateral capsule removal opening (8) at the bottom, characterized by a locking ring (15) which is arranged around the capsule magazine unit (1) and can be displaced essentially vertically with respect to the capsule magazine unit (1), and by at least one locking-ring lifting element (16, 16a) on the holding device (9) for the capsule magazine unit, the said lifting element being suitable for acting on the locking ring (15). <IMAGE>
Patent AU-2004200694-B2 (AU)
Title: Conveyor Belt Cleaner Scraper Blade with Sensor and Control System Therefor
Inventor: SWINDERMANN R TODD
IPC: H01L21/48
Filed: 2004-02-20
Granted: 2007-11-29
Abstract: A conveyor belt cleaner scraper blade (900) for cleaning the surface of a conveyor belt and a method of manufacture of the scraper blade. The scraper blade includes a body having a base member (902) adapted to be attached to a cross shaft (1401) of a conveyor belt cleaner and a scraping member which extends outwardly from the base member to a scraping tip (901). The scraper blade includes one or more electrical sensors (1204,1210) that are embedded in an insert member. The insert member and the sensors are molded and embedded within the body of the scraper blade. Each of the sensors is adapted to provide an electrical output signal representing a physical condition of the scraper blade sensed by the sensor. A variety of sensor embodiments are described, as well as two embodiments of control and monitoring systems for use in conjunction with the various blade and sensor combinations.
Patent AU-2005201123-B2 (AU)
Title: Method and apparatus for arthroscopic bone preparation
Inventor: HAYDEN ADAM
IPC: A61B17/14
Filed: 2005-03-15
Granted: 2010-12-16
Abstract: A guide system for resecting a bone through incisions of the type utilized for arthroscopic procedures comprises a first alignment pin, a second alignment pin and a wire saw. The first alignment pin is configured to be inserted through a first incision into a bone in a first orientation. The second alignment pin is configured to inserted through a second incision into the bone in a second orientation. The first alignment pin and the second alignment pin are configured and oriented to define a resection plane of reference through which the bone is to be resected and the wire saw is configured to be inserted through the first and second incisions to be guided by the first and second alignment pins while being moved to resect the bone.
Patent AU-2005249527-B2 (AU)
Title: Dual small molecule inhibitors of cancer and angiogenesis
Inventor: BROWN MILTON L
IPC: C07D409/04
Filed: 2005-06-01
Granted: 2011-08-04
Abstract: The present invention provides analogs and derivatives of thalidomide which inhibit cancer and angiogenesis. The present invention further provides compounds which disrupt microtubule polymerization. The present further provides methods of treating cancers comprising mutant p53.
Patent AU-2005260887-B2 (AU)
Title: Dendritic cell, drug containing the dendritic cell, therapeutic method using the dendritic cell and method of culturing gamma delta T cell
Inventor: NIEDA MIE
IPC: A61P31/00
Filed: 2005-07-07
Granted: 2010-07-08
Abstract: It is intended to provide a dendritic cell for effectively activating and/or proliferating  ³  ´ T cells  in vivo  and/or  in vitro;  a drug containing the same; a therapeutic method using the dendritic cell; and a method of culturing  ³  ´ T cells using the dendritic cell. An immature dendritic cell originating in peripheral monocyte is pulsed with a bisphosphonate-base bone metabolism-improving agent to thereby impart an ability to activate r ´ T cells. Then it is cultured with cells containing  ³  ´ T cells to thereby activate and/or proliferate the ³ ´ T cells. Thus, ³ ´ T cells can be easily proliferated without placing a burden to a patient, which makes it possible to practically carry out an immunological cell therapy with the use of ³ ´ T cells.
Patent AU-2005262280-B2 (AU)
Title: Container to receive and dispense a measured amount of particulate material
Inventor: LEE ADAM EDWARD
IPC: B65D25/52
Filed: 2005-07-12
Granted: 2012-02-02
Abstract: A container (1) having an interior (5) to receive particulate material (7), said container (1) having: a passage (10) extending between said interior (5) to an opening (15) by which said material (7) is dispensed from said container (1); means located along said passage (10) and operable to limit a measured amount of said material (7) to be dispensed from said container (1) at one time; said means including surfaces (17a-d) offset from each other to alter a direction of said passage (10) to thereby define said measured amount.